Shopping Cart
- Remove All
Your shopping cart is currently empty
Thalidomide-O-amido-PEG-C2-NH2 is a synthesized conjugate formulation designed as an E3 ligase ligand-linker conjugate, incorporating a cereblon ligand based on Thalidomide and a linker component commonly used in PROTAC technology.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | 7-10 days | |
| 50 mg | Inquiry | 7-10 days | |
| 100 mg | Inquiry | 7-10 days |
| Description | Thalidomide-O-amido-PEG-C2-NH2 is a synthesized conjugate formulation designed as an E3 ligase ligand-linker conjugate, incorporating a cereblon ligand based on Thalidomide and a linker component commonly used in PROTAC technology. |
| In vitro | PROTACs consist of two ligands linked together: one ligand targets an E3 ubiquitin ligase, while the other binds to the target protein. These molecules leverage the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| Synonyms | Thalidomide-O-amido-PEG-C2-NH2 |
| Molecular Weight | 418.4 |
| Formula | C19H22N4O7 |
| Cas No. | 2022182-59-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.